A clinical control study of venlafaxine and alprazolam in the treatment of general anxiety disorder
YU Hong-wei
Abstract
YU Hong-wei
Abstract
Objective:To verify the clinical efficacy and the side effects of venlafaxine in the treatment of general anxiety disorder. Methods:68 patients were assigned to velafaxine group and alprazolam group respectively for 6 weeks.The efficacy and side effects were evaluated by HAMA,SAS and TESS before and after 1,2,3,4 and 6 weeks.Results: The efficacy of venlafaxine and alprazolam had no significant difference,but venlafaxine had fewer side effects.Conclusions: Venlafaxine is an effective and safe medicine in the treatment of general anxiety disorder.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To verify the clinical efficacy and the side effects of venlafaxine in the treatment of general anxiety disorder. Methods:68 patients were assigned to velafaxine group and alprazolam group respectively for 6 weeks.The efficacy and side effects were evaluated by HAMA,SAS and TESS before and after 1,2,3,4 and 6 weeks.Results: The efficacy of venlafaxine and alprazolam had no significant difference,but venlafaxine had fewer side effects.Conclusions: Venlafaxine is an effective and safe medicine in the treatment of general anxiety disorder.
Key concepts: Venlafaxine, Alprazolam, Anxiety, Clinical efficacy, Anxiety disorder, Medicine, Generalized anxiety disorder, Venlafaxine Hydrochloride